Andrew Hirsch - Net Worth and Insider Trading
Andrew Hirsch Net Worth
The estimated net worth of Andrew Hirsch is at least $15,800 dollars as of 2025-04-30. Andrew Hirsch is the President & CEO of C4 Therapeutics Inc and owns about 10,000 shares of C4 Therapeutics Inc (CCCC) stock worth over $15,800. Details can be seen in Andrew Hirsch's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Andrew Hirsch has not made any transactions after 2022-04-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Andrew Hirsch
Andrew Hirsch Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Andrew Hirsch owns 4 companies in total, including C4 Therapeutics Inc (CCCC) , Editas Medicine Inc (EDIT) , and Agios Pharmaceuticals Inc (AGIO) among others .
Click here to see the complete history of Andrew Hirsch’s form 4 insider trades.
Insider Ownership Summary of Andrew Hirsch
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| CCCC | C4 Therapeutics Inc | 2022-04-12 | director & See Remarks |
| EDIT | Editas Medicine Inc | 2017-05-30 | director |
| AGIO | Agios Pharmaceuticals Inc | 2016-09-19 | Chief Financial Officer |
 | | 2015-06-22 | director & PRESIDENT & CEO |
Andrew Hirsch Latest Holdings Summary
Andrew Hirsch currently owns a total of 1 stock. Andrew Hirsch owns 10,000 shares of C4 Therapeutics Inc (CCCC) as of April 12, 2022, with a value of $15,800.
Latest Holdings of Andrew Hirsch
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CCCC | C4 Therapeutics Inc | 2022-04-12 | 10,000 | 1.58 | 15,800 |
Holding Weightings of Andrew Hirsch
Andrew Hirsch Form 4 Trading Tracker
According to the SEC Form 4 filings, Andrew Hirsch has made a total of 1 transactions in C4 Therapeutics Inc (CCCC) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in C4 Therapeutics Inc is the acquisition of 10,000 shares on April 12, 2022, which cost Andrew Hirsch around $84,000.
Insider Trading History of Andrew Hirsch
- 1
Andrew Hirsch Trading Performance
GuruFocus tracks the stock performance after each of Andrew Hirsch's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Andrew Hirsch is 10.62%. GuruFocus also compares Andrew Hirsch's trading performance to market benchmark return within the same time period. The performance of stocks bought by Andrew Hirsch within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Andrew Hirsch's insider trading performs compared to the benchmark.
Performance of Andrew Hirsch
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -23.06 | | | | | |
| Relative Return to S&P 500(%) | -12.43 | | | | | |
Andrew Hirsch Ownership Network
Ownership Network List of Andrew Hirsch
Ownership Network Relation of Andrew Hirsch
Andrew Hirsch Owned Company Details
What does C4 Therapeutics Inc do?
Who are the key executives at C4 Therapeutics Inc?
Andrew Hirsch is the director & See Remarks of C4 Therapeutics Inc. Other key executives at C4 Therapeutics Inc include Chief Business Officer Scott N Boyle , Chief Financial Officer Kendra Adams , and Chief Accounting Officer Mark Mossler .
C4 Therapeutics Inc (CCCC) Insider Trades Summary
Over the past 18 months, Andrew Hirsch made no insider transaction in C4 Therapeutics Inc (CCCC). Other recent insider transactions involving C4 Therapeutics Inc (CCCC) include a net sale of 1,159 shares made by Scott N Boyle ,
In summary, during the past 3 months, insiders sold 1,159 shares of C4 Therapeutics Inc (CCCC) in total and bought 0 shares, with a net sale of 1,159 shares. During the past 18 months, 1,159 shares of C4 Therapeutics Inc (CCCC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,159 shares.
C4 Therapeutics Inc (CCCC)'s detailed insider trading history can be found in Insider Trading Tracker table.
C4 Therapeutics Inc Insider Transactions
Andrew Hirsch Mailing Address
Above is the net worth, insider trading, and ownership report for Andrew Hirsch. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Andrew Hirsch's mailing address is: Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
